Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
SMS Co., Ltd. (2175.T)
JPY2,519.00
+78.00 (+3.20%)
JP JPX Healthcare Medical - Healthcare Information Services
Address
Sumitomo Fudosan Shibakoen Tower 105-0011
Tokyo, JP
Tokyo, JP
CEO
Go Fujimoto
Website
bm-sms.co.jp
IPO
2008-03-12
ISIN JP3162350007
Also trades on
Other OTC · SMSZF (USD)
Tokyo Stock Exchange · 2175.T (JPY)
Description
SMS Co., Ltd. provides information infrastructure for the nursing care, medical care, career, healthcare, and elderly care field business areas in Japan and internationally. It operates an online community site for professionals or families engaged in nursing care; a certification course information portal; and a housing information portal for seniors, as well as a home-delivered meal search site. The company also develops medical, health and productivity management support, and global HCP supply platform. In addition, it provides recruiting agent services, as well as recruiting ads services for professionals and operators in nursing and medical care fields. Further, the company offers medical-related services. SMS Co., Ltd. was incorporated in 2003 and is based in Tokyo, Japan.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
JPY2,519.00
+78.00 (+3.20%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
365.5K
Beta
1.30
Float Shares
59.08M
Free Float %
72.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +1.42% | +1.94% | +12.09% | +13.68% | +45.23% | +47.70% | +37.85% | -31.24% | -31.85% | +73.47% | +2,031.71% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
2,519.00
DCF (Unlevered)
1,959.46
-22.2%
DCF (Levered)
1,974.01
-21.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
17% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | -1 |
| Buy | 0 | 0 |
| Hold | 4 | +1 |
| Sell | 0 | 0 |
| Strong Sell | 1 | 0 |
Quality scores
Altman Z-Score
6.38
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
5 / 10
Developing
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+6.2% Q1'26: +8.2% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%-344.8% Q1'26: -987.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%+13.7% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%+10.5% ★ Q1'26: +15.2% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%+33.6% ★ Q1'26: +50.2% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%-3.4% ★ Q1'26: -3.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×0.63× Q1'26: 0.45× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Mar 2015 actual |
Mar 2016 actual |
Mar 2017 actual |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
Mar 2025 actual |
Mar 2026 6 Rev. Ana. 6 EPS Ana. |
Mar 2027 6 Rev. Ana. 5 EPS Ana. |
Mar 2028 6 Rev. Ana. 6 EPS Ana. |
Mar 2029 4 Rev. Ana. 4 EPS Ana. |
Mar 2030 3 Rev. Ana. 2 EPS Ana. |
Mar 2031 2 Rev. Ana. 3 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
15.06B
est: 15.10B (-0.3%)
|
19.07B
est: 19.15B (-0.4%)
|
23.05B
est: 23.72B (-2.8%)
|
26.61B
est: 27.18B (-2.1%)
|
30.84B
est: 31.05B (-0.7%)
|
35.14B
est: 35.14B (0.0%)
|
35.96B
est: 36.52B (-1.5%)
|
38.90B
est: 39.59B (-1.7%)
|
45.67B
est: 46.01B (-0.7%)
|
53.97B
est: 56.21B (-4.0%)
|
60.95B
est: 60.99B (-0.1%)
|
64.75B
64.50B – 65.06B
+6.2% YoY
|
71.14B
70.10B – 71.89B
+9.9% YoY
|
77.60B
74.70B – 79.63B
+9.1% YoY
|
85.72B
85.72B – 85.72B
+10.5% YoY
|
97.20B
94.62B – 99.02B
+13.4% YoY
|
106.80B
103.97B – 108.80B
+9.9% YoY
|
| EBITDA |
2.69B
est: 3.65B (-26.5%)
|
3.74B
est: 4.63B (-19.3%)
|
5.16B
est: 5.74B (-10.0%)
|
5.73B
est: 6.57B (-12.9%)
|
6.61B
est: 7.51B (-12.0%)
|
6.96B
est: 8.50B (-18.2%)
|
7.66B
est: 8.84B (-13.4%)
|
8.80B
est: 9.58B (-8.1%)
|
10.18B
est: 11.13B (-8.6%)
|
11.73B
est: 11.34B (+3.4%)
|
10.15B
est: 12.31B (-17.5%)
|
13.07B
13.02B – 13.13B
+6.2% YoY
|
14.36B
14.15B – 14.51B
+9.9% YoY
|
15.66B
15.08B – 16.07B
+9.1% YoY
|
17.30B
17.30B – 17.30B
+10.5% YoY
|
19.62B
19.10B – 19.98B
+13.4% YoY
|
21.55B
20.98B – 21.96B
+9.9% YoY
|
| EBIT |
2.08B
est: 2.70B (-23.1%)
|
2.76B
est: 3.43B (-19.6%)
|
3.65B
est: 4.25B (-14.1%)
|
4.02B
est: 4.87B (-17.3%)
|
4.74B
est: 5.56B (-14.7%)
|
4.94B
est: 6.29B (-21.5%)
|
5.47B
est: 6.54B (-16.3%)
|
6.32B
est: 7.09B (-10.8%)
|
7.28B
est: 8.24B (-11.6%)
|
8.27B
est: 7.69B (+7.6%)
|
6.34B
est: 8.34B (-24.0%)
|
8.86B
8.82B – 8.90B
+6.2% YoY
|
9.73B
9.59B – 9.83B
+9.9% YoY
|
10.61B
10.22B – 10.89B
+9.1% YoY
|
11.73B
11.73B – 11.73B
+10.5% YoY
|
13.30B
12.94B – 13.54B
+13.4% YoY
|
14.61B
14.22B – 14.88B
+9.9% YoY
|
| Net Income |
1.82B
est: 1.90B (-4.0%)
|
2.27B
est: 2.39B (-5.4%)
|
2.80B
est: 2.90B (-3.6%)
|
3.36B
est: 3.35B (+0.4%)
|
4.22B
est: 3.95B (+6.8%)
|
4.76B
est: 4.50B (+5.8%)
|
4.80B
est: 4.85B (-1.0%)
|
5.41B
est: 5.36B (+0.9%)
|
6.41B
est: 6.13B (+4.5%)
|
7.23B
est: 6.61B (+9.3%)
|
6.05B
est: 5.83B (+3.9%)
|
6.66B
6.33B – 6.98B
+14.2% YoY
|
6.40B
6.14B – 6.80B
-3.9% YoY
|
7.37B
6.74B – 7.95B
+15.2% YoY
|
8.64B
7.53B – 9.99B
+17.3% YoY
|
10.23B
9.88B – 10.48B
+18.4% YoY
|
11.76B
11.35B – 12.04B
+14.9% YoY
|
| SGA |
11.02B
est: 10.18B (+8.2%)
|
13.10B
est: 12.92B (+1.4%)
|
14.16B
est: 16.00B (-11.5%)
|
17.59B
est: 18.33B (-4.0%)
|
20.69B
est: 20.94B (-1.2%)
|
24.14B
est: 23.70B (+1.8%)
|
24.35B
est: 24.63B (-1.2%)
|
25.64B
est: 26.70B (-4.0%)
|
29.92B
est: 31.03B (-3.6%)
|
35.82B
est: 38.28B (-6.4%)
|
43.71B
est: 41.53B (+5.2%)
|
44.09B
43.93B – 44.31B
+6.2% YoY
|
48.45B
47.74B – 48.96B
+9.9% YoY
|
52.85B
50.87B – 54.23B
+9.1% YoY
|
58.38B
58.38B – 58.38B
+10.5% YoY
|
66.19B
64.44B – 67.43B
+13.4% YoY
|
72.73B
70.80B – 74.09B
+9.9% YoY
|
| EPS |
22.36
est: 22.28 (+0.4%)
|
27.93
est: 28.05 (-0.4%)
|
33.74
est: 34.04 (-0.9%)
|
38.71
est: 39.24 (-1.3%)
|
48.50
est: 46.25 (+4.9%)
|
54.69
est: 52.73 (+3.7%)
|
55.12
est: 56.82 (-3.0%)
|
62.07
est: 62.82 (-1.2%)
|
73.51
est: 71.85 (+2.3%)
|
82.96
est: 80.59 (+2.9%)
|
70.96
est: 71.03 (-0.1%)
|
81.36
76.80 – 84.66
+14.6% YoY
|
77.71
74.45 – 82.48
-4.5% YoY
|
89.50
81.72 – 96.44
+15.2% YoY
|
106.18
91.39 – 121.13
+18.6% YoY
|
124.10
119.83 – 127.12
+16.9% YoY
|
142.60
137.69 – 146.07
+14.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-26 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-25 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-19 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-18 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-14 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-13 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-12 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-11 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-08 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-27 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 4/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-15 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
133.25M
OE per share TTM
1.55
Owner's Yield
0.08%
Maintenance CapEx ratio
0.67%
Maint CapEx / Avg PPE
2.1%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
1.56M
Shares Outstanding
82.08M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Masaki Takahata | Chief Executive Officer, President & Representative Director | — | male |
| Masato Sugizaki | Director of Corporate Management & Director | — | male |
| Miori Muroga | Manager of IR & Research | — | — |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 2175.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
